Skip to content
Inciteful Med

Beyond the Surface: Major Organ Involvement in Behçet’s

Last updated:

While known for ulcers, Behçet's disease is a systemic vasculitis that can affect major organs. Inflammation can strike the eyes, blood vessels, brain, and digestive tract, requiring proactive systemic immunosuppression to prevent long-term damage.

Key Takeaways

  • • Behçet's disease is a systemic vasculitis that can cause inflammation in blood vessels throughout the body.
  • • Ocular involvement affects up to 90% of patients and requires prompt treatment to prevent vision loss.
  • • Vascular complications most commonly appear as deep vein thrombosis (blood clots) in the legs.
  • • Neurological and gastrointestinal involvements can cause persistent headaches, balance issues, and abdominal pain.
  • • When major organs are involved, treatment shifts to systemic immunosuppression to protect against long-term damage.

While Behçet’s disease is well-known for causing mouth and genital ulcers, it is fundamentally a systemic vasculitis—a condition where inflammation can strike blood vessels in any part of the body [1][2]. When inflammation moves beyond the skin and mucous membranes, it is often categorized into specific “subtypes” based on which organ system is involved.

Understanding these involvements is critical, as they represent the most serious aspects of the disease and require specialized, proactive management [3][4].

Ocular Behçet’s: Protecting Your Vision

Ocular (eye) involvement occurs in up to 90% of patients and is one of the most common “major” involvements [5].

  • Uveitis: This is internal inflammation of the eye [5]. It can affect the front (anterior), back (posterior), or the entire eye (panuveitis) [6].
  • Retinal Vasculitis: This occurs when the inflammation attacks the blood vessels in the retina (the light-sensing part of the eye) [7].
  • The Goal: If left untreated, chronic inflammation can lead to permanent vision loss [6]. However, modern biologic therapies (like TNF-inhibitors) have significantly reduced this risk, often saving vision even in severe cases [8][9].

Vascular Behçet’s (VBD): Protecting Your Blood Vessels

Vascular involvement affects the blood vessels themselves and requires careful monitoring [10][11].

  • Venous Involvement: This is the most common form, often appearing as deep vein thrombosis (DVT)—blood clots typically in the legs [12][13].
  • Arterial Involvement: While rarer, arterial issues are more complex [14]. The hallmark is the formation of aneurysms (weakened, bulging spots in artery walls), such as pulmonary artery aneurysms (PAA) in the lungs [15][16].
  • The Reality: While vascular involvement is a leading cause of severe complications, it is important to know that catastrophic events like ruptured aneurysms are rare, especially when you are actively monitored and treated with immune-suppressing medications [10][17].

Neuro-Behçet’s Disease (NBD): The Nervous System

When Behçet’s affects the brain or spinal cord, it is divided into two categories [18]:

  • Parenchymal (p-NBD): This involves inflammation of the brain tissue itself, often the brainstem [19]. Symptoms can include weakness, difficulty swallowing, or balance issues [19][20].
  • Non-Parenchymal (non-p-NBD): This affects the blood vessels around the brain, most commonly leading to cerebral venous thrombosis (a clot in the brain’s drainage system) [18]. This often presents as a severe, persistent headache [19][21].

Gastrointestinal (GI) Behçet’s: Protecting Your Digestive Tract

GI involvement occurs when ulcers form in the digestive tract, most commonly in the ileocecal region (where the small and large intestines meet) [22][23].

  • Symptoms: Persistent abdominal pain, diarrhea, or bloody stools [24].
  • The Reality: Deep ulcers can lead to complications, but massive bleeding or perforation is very rare; early treatment usually heals these ulcers before they cause structural damage [25][26].

Managing Major Organ Involvement

If you have any of these involvements, your care will transition from “symptom management” (like creams for ulcers) to systemic immunosuppression [27]. The goal is to quiet the immune system enough to protect these vital organs from long-term damage [28][29]. Early recognition of these signs is the most effective way to ensure a positive long-term outcome. Next, learn about the medications used in The Road to Remission.

Frequently Asked Questions

How does Behçet's disease affect the eyes?
Behçet's can cause internal eye inflammation like uveitis or retinal vasculitis. Watch for vision changes such as floaters, blurriness, or light sensitivity, as untreated inflammation can lead to permanent vision loss.
What are the signs of vascular involvement in Behçet's?
Vascular involvement often appears as deep vein thrombosis, causing localized pain, swelling, and warmth in the legs. In rarer cases, it can cause aneurysms in artery walls, such as those in the lungs.
What neurological symptoms should I watch for with Behçet's?
You should watch for subtle neurological changes like new difficulty with balance, swallowing issues, or weakness. Severe, persistent headaches can also indicate inflammation of the blood vessels around the brain.
What are the symptoms of gastrointestinal Behçet's?
Gastrointestinal involvement happens when ulcers form in the digestive tract, usually where the small and large intestines meet. Symptoms can include persistent abdominal pain, diarrhea, or bloody stools.
Will my treatment change if Behçet's affects my major organs?
Yes. If Behçet's affects your major organs, care typically shifts from basic symptom management to systemic immunosuppression. The goal is to quiet your immune system enough to protect your vital organs from permanent damage.

Questions for Your Doctor

  • • Based on my symptoms, should I have a baseline eye exam or imaging to check for 'silent' organ involvement?
  • • Am I at higher risk for vascular complications, and how often should we screen for these?
  • • Is my eye inflammation considered 'panuveitis' or 'retinal vasculitis,' and how does that change my long-term vision prognosis?
  • • If I develop persistent abdominal pain, what imaging or tests should we use to distinguish between Behçet’s ulcers and other issues?
  • • What is the current goal for my inflammatory markers (like CRP or ESR) to ensure my major organs are protected?

Questions for You

  • • Have I noticed any subtle neurological changes, such as new difficulty with balance, swallowing, or persistent headaches?
  • • Do I experience localized pain, swelling, or warmth in my legs that could indicate a blood clot?
  • • Am I having any vision changes like 'floaters,' blurriness, or sensitivity to light, even if they seem to come and go?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [An aortic and femoral aneurysm revealing Behçet's disease].

    Lyazidi Y, Abissegue Y, Chtata HT, Taberkant M

    Journal des maladies vasculaires 2015; (40(6)):399-401.

    PMID: 26460187
  2. 2

    Multiple Intracranial Aneurysms Associated with Behçet's Disease.

    Ha S, Kim J, Kim CG, Jang SJ

    Journal of cerebrovascular and endovascular neurosurgery 2016; (18(1)):32-7 doi:10.7461/jcen.2016.18.1.32.

    PMID: 27114964
  3. 3

    Focus on neuro-Behçet's disease: A review.

    Caruso P, Moretti R

    Neurology India 2018; (66(6)):1619-1628 doi:10.4103/0028-3886.246252.

    PMID: 30504554
  4. 4

    Behçet's disease physiopathology: a contemporary review.

    Zeidan MJ, Saadoun D, Garrido M, et al.

    Auto- immunity highlights 2016; (7(1)):4 doi:10.1007/s13317-016-0074-1.

    PMID: 26868128
  5. 5

    Clinical Features of Behçet's Disease Uveitis.

    Yalçindag N, Oklar M

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2025; (39(4)):290-298 doi:10.4103/sjopt.sjopt_163_24.

    PMID: 41367832
  6. 6

    [Ocular manifestations of Behçet's disease].

    Saadouli D, Lahmar A, Ben Mansour K, et al.

    Journal francais d'ophtalmologie 2021; (44(2)):196-202 doi:10.1016/j.jfo.2020.04.058.

    PMID: 33380351
  7. 7

    Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.

    Bazvand F, Zarei M, Ebrahimiadib N, et al.

    Seminars in ophthalmology 2017; (32(6)):764-771 doi:10.1080/08820538.2016.1178310.

    PMID: 27715380
  8. 8

    [Uveitis in Behçet's Syndrome in Germany - Prognosis During Current Therapy].

    Stübiger N, Deuter C, Doycheva D

    Klinische Monatsblatter fur Augenheilkunde 2020; (237(5)):591-598 doi:10.1055/a-1140-3295.

    PMID: 32434242
  9. 9

    Behçet's disease uveitis.

    Joubert M, Desbois AC, Domont F, et al.

    La Revue de medecine interne 2023; (44(10)):546-554 doi:10.1016/j.revmed.2023.06.004.

    PMID: 37414674
  10. 10

    Pulmonary Artery Aneurysm in Behcet Disease: Medical, Endovascular or Surgical Intervention.

    Samreen I, Darji P, Genobaga S, et al.

    Cureus 2023; (15(11)):e49368 doi:10.7759/cureus.49368.

    PMID: 38146562
  11. 11

    Management of vascular Behçet's disease.

    Alibaz-Oner F, Direskeneli H

    International journal of rheumatic diseases 2019; (22 Suppl 1()):105-108 doi:10.1111/1756-185X.13298.

    PMID: 29665281
  12. 12

    Vascular Behçet syndrome: from pathogenesis to treatment.

    Bettiol A, Alibaz-Oner F, Direskeneli H, et al.

    Nature reviews. Rheumatology 2023; (19(2)):111-126 doi:10.1038/s41584-022-00880-7.

    PMID: 36544027
  13. 13

    Vascular Involvement in Behcet's Disease: An Evaluation of 147 Cases and Literature Review.

    Atalar E, Erten S, Dogan I, Konak HE

    Sisli Etfal Hastanesi tip bulteni 2023; (57(3)):380-386 doi:10.14744/SEMB.2023.89083.

    PMID: 37900329
  14. 14

    Blue Toe Syndrome in Behçet's Disease: A Case Report.

    Aljarrah Q, Ba-Shammakh SA, Allouh MZ, Afaneh MW

    The American journal of case reports 2024; (25()):e943813 doi:10.12659/AJCR.943813.

    PMID: 38907515
  15. 15

    Cardiovascular Manifestations in Behçet's Disease.

    Kim J

    Yonsei medical journal 2024; (65(9)):493-500 doi:10.3349/ymj.2023.0578.

    PMID: 39193757
  16. 16

    Dyspnea and hemoptysis revealing Behçet's syndrome: Pulmonary artery aneurysms in a case report.

    Ez-Zaky S, Laasri I, Jroundi L, Laamrani FZ

    Radiology case reports 2025; (20(1)):115-118 doi:10.1016/j.radcr.2024.09.110.

    PMID: 39484046
  17. 17

    Concurrent Pulmonary Artery Aneurysm, Pulmonary Thrombosis, and Intracardiac Thrombus in Behçet's Disease: A Case Report.

    Alagha OA, Abu ElQomboz AY, Alsarafandi SF

    Cureus 2023; (15(8)):e43993 doi:10.7759/cureus.43993.

    PMID: 37746357
  18. 18

    Inflammatory cerebral pseudotumour as a rare manifestation of neuro-Behçet's disease: A case report and literature review.

    Porto Fuentes Ó, Lacruz Ballester L, Álvarez Troncoso J, et al.

    Journal of neuroimmunology 2025; (405()):578652 doi:10.1016/j.jneuroim.2025.578652.

    PMID: 40446741
  19. 19

    Clinical and imaging features of parenchymal and non-parenchymal neuro-Behçet's disease: a systematic review of case reports and series.

    Al-Omoush O, AlBarakat MM, Alasmar D, et al.

    BMC neurology 2025; (25(1)):225 doi:10.1186/s12883-025-04250-0.

    PMID: 40419971
  20. 20

    Neuro-Behçet leading to coma: A case report.

    Kriouile S, Imrani K, Graini SE, et al.

    Radiology case reports 2025; (20(1)):625-628 doi:10.1016/j.radcr.2024.10.102.

    PMID: 39583234
  21. 21

    Neuro-Behçet Disease in the Central University Hospital of Asturias.

    Charca-Benavente LC, Gómez de la Torre R, Caminal-Montero L, et al.

    Reumatologia clinica 2021; (17(1)):32-36 doi:10.1016/j.reuma.2019.03.005.

    PMID: 31078455
  22. 22

    Intestinal Behçet and Crohn's disease: two sides of the same coin.

    Valenti S, Gallizzi R, De Vivo D, Romano C

    Pediatric rheumatology online journal 2017; (15(1)):33 doi:10.1186/s12969-017-0162-4.

    PMID: 28427473
  23. 23

    [Surgical Resection of an Ascending Colon Tumor Suspected to Represent Intestinal Behçet's Disease-A Case Report].

    Funaoka K, Yamada R, Hatayama R, et al.

    Gan to kagaku ryoho. Cancer & chemotherapy 2025; (52(10)):761-763.

    PMID: 41139976
  24. 24

    Successful Treatment of Refractory Mucocutaneous Behçet's Disease With Gastrointestinal Involvement Using Anti-tumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy.

    Elfatih Mohamed M, Mazin Al-Issa R, Ahmed H, et al.

    Cureus 2025; (17(5)):e84937 doi:10.7759/cureus.84937.

    PMID: 40585706
  25. 25

    Neutropenic Enterocolitis in Acute Myeloid Leukemia and Morbus Behcet: Pivotal Role of Medical Imaging and Multidisciplinary Management in a Complex Clinical Case.

    Dascalescu CA, Fraccaroli A, Gaitzsch E, et al.

    In vivo (Athens, Greece) 2025; (39(5)):3008-3013 doi:10.21873/invivo.14102.

    PMID: 40877152
  26. 26

    Advances in Management of Intestinal Behçet's Disease: A Perspective From Gastroenterologists.

    Cheon JH

    Journal of rheumatic diseases 2021; (28(1)):4-16 doi:10.4078/jrd.2021.28.1.4.

    PMID: 37476392
  27. 27

    Isolated brachial artery aneurysm: a rare presentation of paediatric Behçet's disease.

    Naik AL, Savlania A, Gupta A, et al.

    Annals of the Royal College of Surgeons of England 2021; (103(3)):e94-e97 doi:10.1308/rcsann.2020.7037.

    PMID: 33645285
  28. 28

    Management of patients with Behçet's disease during the COVID-19 pandemic.

    Dursun R, Temiz SA, Özer İ, et al.

    Dermatologic therapy 2020; (33(6)):e14063 doi:10.1111/dth.14063.

    PMID: 32710599
  29. 29

    Adamantiades-Behçet's disease therapy: current treatment options and recommendations with regard to the COVID-19 pandemic.

    Trevisini S, Trevisan G, Zalaudek I, Bonin S

    Dermatologic therapy 2022; (35(3)):e15286 doi:10.1111/dth.15286.

    PMID: 34962035

This page provides educational information about major organ involvement in Behçet's disease. It does not replace professional medical advice. Always consult your rheumatologist or specialist regarding your specific symptoms and treatment.

Stay up to date

Get notified when new research about Behçet disease is published.

No spam. Unsubscribe anytime.